Hipoglicemia severa secundaria a captopril. Informe de casos

Authors

  • Rafael Pila Pérez
  • Rafael Pila Peláez
  • Miguel Paulino Basulto
  • Juan del Sol Sosa
  • Francisco López Franco

Abstract

Se presentaron dos casos de hipertensión arterial con hipoglucemias severas que recibieron tratamiento con inhibidor de la enzima convertidora de angiotencia (IACE) y requirieron hospitalización. Se señala el cuadro clínico y la repercusión del empleo de estos medicamentos en los enfermos hipertensos diabéticos, poco mencionado por nuestros médicos.

Downloads

Download data is not yet available.

Downloads

Published

2015-01-12

How to Cite

1.
Pila Pérez R, Pila Peláez R, Paulino Basulto M, del Sol Sosa J, López Franco F. Hipoglicemia severa secundaria a captopril. Informe de casos. Arch méd Camagüey [Internet]. 2015 Jan. 12 [cited 2025 Aug. 3];9(3). Available from: https://revistaamc.sld.cu/index.php/amc/article/view/3026

Issue

Vol. 9 No. 3 (2005)

Section

Case Reports

License

Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.

Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.

(Download Statement of potential conflicts of interest)

The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).

This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/